Chimerix, Inc. - stock earnings
CMRX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 BeforeMarket | -0.25 / -0.22 | - | - / 51000 | - |
| Aug. 1, 2024 BeforeMarket | - / - | - | - / 40000 | 250000 |
CMRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -21.9 million USD | ? USD |
| 2023Q4 | -18.2 million USD | 4000 USD |
| 2023Q3 | -24.0 million USD | 11000 USD |
| 2023Q2 | -18.6 million USD | 26000 USD |
| 2023Q1 | -18.5 million USD | 283000 USD |
| 2022Q4 | -21.0 million USD | 814000 USD |
| 2022Q3 | 241.4 million USD | 32.6 million USD |
| 2022Q2 | -23.5 million USD | 440000 USD |
| 2022Q1 | -24.8 million USD | 15000 USD |
| 2021Q4 | -39.5 million USD | 46000 USD |
| 2021Q3 | -18.6 million USD | 107000 USD |
| 2021Q2 | -17.8 million USD | 391000 USD |
| 2021Q1 | -97.4 million USD | 1.4 million USD |
| 2020Q4 | -11.7 million USD | 1.1 million USD |
| 2020Q3 | -11.4 million USD | 1.6 million USD |
| 2020Q2 | -10.0 million USD | 1.4 million USD |
| 2020Q1 | -10.4 million USD | 1.2 million USD |
| 2019Q4 | -3.5 million USD | 6.8 million USD |
| 2019Q3 | -73.7 million USD | 2.0 million USD |
| 2019Q2 | -17.7 million USD | 1.4 million USD |
| 2019Q1 | -17.7 million USD | 2.4 million USD |
| 2018Q4 | -15.0 million USD | 4.9 million USD |
| 2018Q3 | -16.1 million USD | 369000 USD |
| 2018Q2 | -18.6 million USD | 1.2 million USD |
| 2018Q1 | -19.8 million USD | 790000 USD |
| 2017Q4 | -19.2 million USD | 1.8 million USD |
| 2017Q3 | -17.3 million USD | 897000 USD |
| 2017Q2 | -16.7 million USD | 675000 USD |
| 2017Q1 | -17.8 million USD | 1.1 million USD |
| 2016Q4 | -15.0 million USD | 2.0 million USD |
| 2016Q3 | -17.0 million USD | 653000 USD |
| 2016Q2 | -18.1 million USD | 1.8 million USD |
| 2016Q1 | -26.3 million USD | 1.2 million USD |
| 2015Q4 | -37.8 million USD | 3.1 million USD |
| 2015Q3 | -32.4 million USD | 2.3 million USD |
| 2015Q2 | -24.8 million USD | 4.1 million USD |
| 2015Q1 | -22.3 million USD | 1.2 million USD |
| 2014Q4 | -20.2 million USD | 1.2 million USD |
| 2014Q3 | -17.0 million USD | 1.2 million USD |
| 2014Q2 | -11.7 million USD | 919000 USD |
| 2014Q1 | -10.4 million USD | 780000 USD |
| 2013Q4 | -8.2 million USD | 879000 USD |
| 2013Q3 | -6.7 million USD | 912000 USD |
| 2013Q2 | -12.5 million USD | 808000 USD |
| 2013Q1 | -9.1 million USD | 1.8 million USD |
| 2012Q4 | -4.3 million USD | 3.6 million USD |
| 2012Q3 | 11.1 million USD | 20.9 million USD |
| 2012Q2 | -4.3 million USD | 6.2 million USD |
| 2012Q1 | -6.9 million USD | 3.1 million USD |
| 2011Q4 | ? USD | 12.1 million USD |
CMRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.1 million USD | 324000 USD |
| 2022 | 172.2 million USD | 33.8 million USD |
| 2021 | -255.8 million USD | 2.0 million USD |
| 2020 | -42.1 million USD | 5.4 million USD |
| 2019 | -173.7 million USD | 12.5 million USD |
| 2018 | -69.5 million USD | 7.2 million USD |
| 2017 | -71.0 million USD | 4.5 million USD |
| 2016 | -76.4 million USD | 5.7 million USD |
| 2015 | -117.4 million USD | 10.8 million USD |
| 2014 | -59.3 million USD | 4.0 million USD |
| 2013 | -36.4 million USD | 4.4 million USD |
| 2012 | -4.4 million USD | 33.7 million USD |
| 2011 | -25.6 million USD | 12.1 million USD |
| 2010 | -25.5 million USD | 1.7 million USD |
CMRX
Price: $0.97
52 week price:
Earnings Per Share: -0.94 USD
P/E Ratio: -0.97
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 701000
Ebitda: -17.6 millionMarket Capitalization: 86.5 million